Data challenges in decentralized clinical trials
In the span of a few months, the COVID-19 pandemic has greatly accelerated the adoption of decentralized clinical trials. According to a recent survey of 252 clinical research professionals conducted by Informa Engage on behalf of Oracle, 76% of clinical trial teams say they have sped up the use of decentralized trials methods, and just less than half are looking at new vendors to help in the process.
More Ways to Read:
🧃
Summarize
--
The key takeaways that can be read in under a minute
Sign up to unlock
Worth the squeeze
Get access to the condensed version of this piece, and every other article on The Juice, and so much more.
Start a free account on The Juice and we'll send you weekly emails sharing which podcasts, blogs, guides,
etc. are trending with other marketing or sales pros. We call it the Top 5!
Other content from
Oracle
Featured by Salesforce
